0000096021-22-000193.txt : 20221025
0000096021-22-000193.hdr.sgml : 20221025
20221025170759
ACCESSION NUMBER: 0000096021-22-000193
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221024
FILED AS OF DATE: 20221025
DATE AS OF CHANGE: 20221025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hourican Kevin
CENTRAL INDEX KEY: 0001741853
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06544
FILM NUMBER: 221330231
MAIL ADDRESS:
STREET 1: ONE CVS DRIVE
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYSCO CORP
CENTRAL INDEX KEY: 0000096021
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-GROCERIES & RELATED PRODUCTS [5140]
IRS NUMBER: 741648137
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0702
BUSINESS ADDRESS:
STREET 1: 1390 ENCLAVE PKWY
CITY: HOUSTON
STATE: TX
ZIP: 77077
BUSINESS PHONE: 281-584-1390
MAIL ADDRESS:
STREET 1: 1390 ENCLAVE PKWY
CITY: HOUSTON
STATE: TX
ZIP: 77077
4
1
wf-form4_166673206196734.xml
FORM 4
X0306
4
2022-10-24
0
0000096021
SYSCO CORP
SYY
0001741853
Hourican Kevin
1390 ENCLAVE PARKWAY
HOUSTON
TX
77077
1
1
0
0
President and CEO
Common Stock
2022-10-24
4
M
0
75019
58.08
A
378661.854
D
Common Stock
2022-10-24
4
S
0
75019
81.22
D
303642.854
D
Stock Options (Right to buy)
58.08
2022-10-24
4
M
0
75019
0
D
2030-08-19
Common Stock
75019.0
75019
D
The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan.
The price reported is a weighted average sale price per share of the 75,019 shares sold on this date. These shares were sold in multiple transactions at prices ranging from $80.37 to $81.82. The Reporting Person undertakes to provide Sysco Corporation, any security holder of Sysco Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding number of shares sold at each separate price within the ranges set forth in the footnote of this Form 4.
Options are fully exercisable.
Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan.
/s/ Gerald W. Clanton, Attorney-in-fact
2022-10-25